Telix Pharmaceuticals (TLPPF) Property, Plant & Equipment (Net) (2023 - 2026)
Analysis
Telix Pharmaceuticals (TLPPF) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.49 Bn | 198.50 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 180.93 Bn | 177.75 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.39 Bn | 124.53 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 82.17 Bn | 74.18 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.05 Bn | 55.87 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 55.19 Bn | 50.05 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 33.99 Bn | 30.68 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 29.91 Bn | 29.91 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Telix Pharmaceuticals | 3.72 Bn | 3.43 Bn | - | 873.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 873.83 Mn |
| Dec 31, 2025 | 833.71 Mn |
| Dec 31, 2024 | 390.98 Mn |
| Dec 31, 2023 | 112.92 Mn |